Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Seminars in Cancer Biology
|
August 1, 2020
Can medical imaging identify the histopathological growth patterns of liver metastases?
Emily Latacz, Pieter-Jan van Dam, Christian Vanhove, et al.
BMC Cancer
|
May 30, 2019
PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer
Sandra Tuyaerts, An M T Van Nuffel, Eline Naert, et al.
JAMA Network Open
|
February 12, 2024
Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases: A Systematic Review and Meta-Analysis
Bas J J Bindels, Carole Mercier, Roxanne Gal, et al.
European Urology Focus
|
February 19, 2025
Adjuvant Radiotherapy After Radical Cystectomy for Muscle-invasive Bladder Cancer: A Phase 2 Trial-Results of Secondary Endpoints
Flor Verghote, Elke Rammant, Piet Dirix, et al.
BMC Cancer
|
October 19, 2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial
Flor Verghote, Lindsay Poppe, Sofie Verbeke, et al.
JMIR Research Protocols
|
December 15, 2018
Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial
Cédric Draulans, Steven Joniau, Valérie Fonteyne, et al.
JAMA Oncology
|
July 6, 2023
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors: The CHEERS Phase 2 Randomized Clinical Trial
Mathieu Spaas, Nora Sundahl, Vibeke Kruse, et al.
BMC Cancer
|
May 8, 2021
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial
Mathieu Spaas, Nora Sundahl, Eva Hulstaert, et al.
Breast Cancer Research and Treatment
|
February 12, 2020
Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity
Charlotte Rypens, Melike Marsan, Christophe Van Berckelaer, et al.
European Urology Oncology
|
September 25, 2025
Stage Migration on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Comparison to Conventional Imaging in Patients with High-risk Prostate Cancer Referred for Radiation Therapy: Results from the Phase 2/3 THUNDER Trial
Fleur Kleiburg, Piet Dirix, Valérie Fonteyne, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Seminars in Cancer Biology
|
August 1, 2020
Can medical imaging identify the histopathological growth patterns of liver metastases?
Emily Latacz, Pieter-Jan van Dam, Christian Vanhove, et al.
BMC Cancer
|
May 30, 2019
PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer
Sandra Tuyaerts, An M T Van Nuffel, Eline Naert, et al.
JAMA Network Open
|
February 12, 2024
Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases: A Systematic Review and Meta-Analysis
Bas J J Bindels, Carole Mercier, Roxanne Gal, et al.
European Urology Focus
|
February 19, 2025
Adjuvant Radiotherapy After Radical Cystectomy for Muscle-invasive Bladder Cancer: A Phase 2 Trial-Results of Secondary Endpoints
Flor Verghote, Elke Rammant, Piet Dirix, et al.
BMC Cancer
|
October 19, 2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial
Flor Verghote, Lindsay Poppe, Sofie Verbeke, et al.
JMIR Research Protocols
|
December 15, 2018
Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial
Cédric Draulans, Steven Joniau, Valérie Fonteyne, et al.
JAMA Oncology
|
July 6, 2023
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors: The CHEERS Phase 2 Randomized Clinical Trial
Mathieu Spaas, Nora Sundahl, Vibeke Kruse, et al.
BMC Cancer
|
May 8, 2021
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial
Mathieu Spaas, Nora Sundahl, Eva Hulstaert, et al.
Breast Cancer Research and Treatment
|
February 12, 2020
Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity
Charlotte Rypens, Melike Marsan, Christophe Van Berckelaer, et al.
European Urology Oncology
|
September 25, 2025
Stage Migration on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Comparison to Conventional Imaging in Patients with High-risk Prostate Cancer Referred for Radiation Therapy: Results from the Phase 2/3 THUNDER Trial
Fleur Kleiburg, Piet Dirix, Valérie Fonteyne, et al.
Page
of 10